Novartis Inflammasome Research Inc

IFM Tre, Inc. operates as a bio-pharmaceutical company. The Company develops small-molecule antagonists and drug candidates to address metabolic, fibrotic, autoimmune, autoinflammatory, and neurodegenerative diseases. IFM Tre serves cleints in the States of Massachusetts.